Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)
- Authors: Vinnitskaya EV1, Abdulkhakov SR2, Abdurakhmanov DT3, Alikhanov RB1, Bakulin IG4, Belousova EA5, Bueverov AO3, Burnevitch EZ3, Efanov MG1, Eremina EY.6, Ignatova TM3, Ilchenko LY.7, Karmazanovsky GG8, Knyazev OV1, Kulezneva Y.V1, Lopatkina TN3, Nekrasova TP3, Nikitin IG7, Pavlenko VV9, Parfenov AI1, Podymova SD1, Raichelson KL10, Reisis AR11, Sayfutdinov RG12, Skazyvaeva EV4, Syutkin VE13, Khomeriki SG1, Haimenova TY.1, Sandler Y.G1
-
Affiliations:
- A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscow
- Kazan Federal University
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
- I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federation
- M.F. Vladimirsky Moscow Regional Research Clinical Institute
- Medical Institut of the N.P. Ogarev Mordovia State University
- N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- A.V. Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federation
- Stavropol State Medical University of the Ministry of Health of the Russian Federation
- St Petersburg State University
- Central Research Institute of Epidemiology of the Federal Service on Customers
- Kazan State Medical Academy - the Branch of Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
- N.V. Sklifosovsky Research Institute of Emergency Medical Care of the Department of Health of Moscow
- Issue: Vol 91, No 2 (2019)
- Pages: 9-15
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32896
- DOI: https://doi.org/10.26442/00403660.2019.02.000075
- ID: 32896
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
E V Vinnitskaya
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscow
Email: e.vinnitskaya@mknc.ru
д.м.н., зав. отд. гепатологии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
S R Abdulkhakov
Kazan Federal Universityк.м.н., с.н.с., ФГАОУ ВО КФУ Kazan, Russia
D T Abdurakhmanov
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)д.м.н., проф., ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
R B Alikhanov
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowк.м.н., зав. отд-нием хирургии печени и поджелудочной железы ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
I G Bakulin
I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federationд.м.н., проф., ФГБОУ ВО «СЗГМУ им. И.И. Мечникова» Saint Petersburg, Russia
E A Belousova
M.F. Vladimirsky Moscow Regional Research Clinical Instituteд.м.н., проф., зав. каф. гастроэнтерологии ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского» Moscow, Russia
A O Bueverov
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)д.м.н., профессор, ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
E Z Burnevitch
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)к.м.н., ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
M G Efanov
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., проф., руководитель отд. гепатобилиарной хирургии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
E Yu Eremina
Medical Institut of the N.P. Ogarev Mordovia State Universityд.м.н., проф., зав. каф. пропедевтики внутренних болезней Медицинского института ФГБОУ ВО «НИМГУ им. Н.П. Огарева» Saransk, Russia
T M Ignatova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)д.м.н., ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
L Yu Ilchenko
N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federationд.м.н., проф., ФГБОУ ВО «РНИМУ им. Н.И. Пирогова» Moscow, Russia
G G Karmazanovsky
A.V. Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federationд.м.н., проф., ФГБУ «Институт хирургии им. А.В. Вишневского» Moscow, Russia
O V Knyazev
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., зав. отд-нием воспалительных заболеваний кишечника ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
Yu V Kulezneva
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., зав. отд. лучевых методов диагностики и лечения ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
T N Lopatkina
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)к.м.н., доц., ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
T P Nekrasova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)к.м.н., доц. каф. патологической анатомии ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Moscow, Russia
I G Nikitin
N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federationд.м.н., проф., ФГБОУ ВО «РНИМУ им. Н.И. Пирогова» Moscow, Russia
V V Pavlenko
Stavropol State Medical University of the Ministry of Health of the Russian Federationд.м.н., проф., зав. каф. терапии ФГБОУ ВО СтГМУ Stavropol, Russia
A I Parfenov
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., проф., зав. отд. патологии кишечника ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
S D Podymova
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., проф., в.н.с. отд. гепатологии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
K L Raichelson
St Petersburg State Universityд.м.н., проф. научно-клинического и образовательного центра гастроэнтерологии и гепатологии Института высоких медицинских технологий ФГБОУ ВО СПбГУ Saint Petersburg, Russia
A R Reisis
Central Research Institute of Epidemiology of the Federal Service on Customersд.м.н., проф. научно-консультативного клинико-диагностического центра ЦНИИ Эпидемиологии Moscow, Russia
R G Sayfutdinov
Kazan State Medical Academy - the Branch of Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federationд.м.н., проф., зав. каф. КГМА - филиал ФГБОУ ДПО РМАНПО Kazan, Russia
E V Skazyvaeva
I.I. Mechnikov North-Western State Medical University of the Ministry of Health of the Russian Federationк.м.н., врач-терапевт и гастроэнтеролог ФГБОУ ВО «СЗГМУ им. И.И. Мечникова» Saint Petersburg, Russia
V E Syutkin
N.V. Sklifosovsky Research Institute of Emergency Medical Care of the Department of Health of Moscowд.м.н., проф., ГБУЗ «НИИ СП им. Н.В. Склифосовского» ДЗМ Moscow, Russia
S G Khomeriki
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., проф., зав. лаб. патоморфологии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
T Yu Haimenova
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowд.м.н., проф., зав. лаб. патоморфологии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
Yu G Sandler
A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of Moscowк.м.н., с.н.с. научно-исследовательского отд. гепатологии ГБУЗ «МКНЦ им. А.С. Логинова» ДЗМ Moscow, Russia
References
- Molodecky N.A, Kareemi H, Parab R, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta - analysis. Hepatology. 2011;53(5):1590-9. doi: 10.1002/hep.24247
- Williamson K.D, Chapman R.W. New Therapeutic Strategies for Primary Sclerosing Cholangitis. Semin Liver Dis. 2016;36(1):5-14. doi: 10.1055/s-0035-1571274
- Karlsen T.H, Franke A, Melum E, Kaser A, Hov J.R, Balschun T, Lie B.A, Bergquist A, Schramm C, Weismüller T.J, et al. Genome - wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2010 Mar;138(3):1102-11. doi: 10.1053/j.gastro.2009.11.046
- Melum E, Franke A, Schramm C, Weismüller T.J, Gotthardt D.N, Offner F.A, Juran B.D, Laerdahl J.K, Labi V, Björnsson E, et al. Genome - wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet. 2011;43:17-9. doi: 10.1038/ng.728
- Grant A.J, Lalor P.F, Salmi M, Jalkanen S, Adams D.H. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet. 2002;359(9301):150-7. doi: 10.1016/S0140-6736(02)07374-9
- Seidel D, Eickmeier I, Kühl A.A, Hamann A, Loddenkemper C, Schott E. CD8 T cells primed in the gut - associated lymphoid tissue induce immune - mediated cholangitis in mice. Hepatology. 2014;59(2):601-11. doi: 10.1002/hep.26702
- Sarkar S, Bowlus C.L. PSC: multiple phenotypes, multiple approaches. Clin Liver Dis. 2016;20(1):67-77. doi: 10.1016/j.cld.2015.08.005
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237-67. doi: 10.1016/j.jhep.2009.04.009
- Chapman R, Fevery J, Kalloo A, Nagorney D.M, Boberg K.M, Shneider B, Gores G.J; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010 Feb;51(2):660-78. doi: 10.1002/hep.23294
- Al Mamari S, Djordjevic J, Halliday J.S, Chapman R.W. Improvement of serum alkaline phosphatase to 1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol. 2013;58:329-34. doi: 10.1016/j.jhep.2012.10.013
- Hilscher M, Enders F.B, Carey E.J, Lindor K.D, Tabibian J.H. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Ann Hepatol. 2016;15(2):246-53.
- Steele.IL, Levy C, Lindor K.D. Primary sclerosing cholangitis - approach to diagnosis. Med Gen Med. 2007;9:20. PMCID: PMC1994832.
- Hov J.R, Boberg K.M, Karlsen T.H. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol. 2008;14(24):3781-91. doi: 10.3748/wjg.14.3781
- Angulo P, Peter J.B, Gershwin M.E, De Sotel C.K, Shoenfeld Y, Ahmed A.E, Lindor K.D. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol. 2000;32:182-7. doi: 10.1016/s0168-8278(00)80061-6
- Ludwig J, Colina F, Poterucha J.J. Granulomas in primary slerosing cholangitis. Liver. 1995;15:307-12. doi: 10.1111/j.1600-0676.1995.tb00690.x
- Anders B.M, Anesa M, Trygve H, Roald F.H, Odd H.G, Mette V. Ultrasound and point shear wave elastography in livers of patients with primary sclerosing cholangitis. Ultrasound Med Biol. 2016;42(9):2146-55. doi: 10.1016/j.ultrasmedbio.2016.04.016
- Aabakken L, Karlsen T.H, Albert J, Arvanitakis M, et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. J Hepatol. 2017 Jun;66(6):1265-81. doi: 10.1016/j.jhep.2017.02.013
- Schramm C, Eaton J, Ringe K.I, Venkatesh S, Yamamura J; for the MRI working group of the IPSCSG (2017). Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017;66:1675-88. doi: 10.1002/hep.29293
- Dave M, Elmunzer B.J, Dwamena B.A, Higgins PDR. Primary sclerosing cholangitis: meta - analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010;256(2). doi: 10.1148/radiol.10091953
- Lindor K, Kowdley K, Harrison E. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015 Apr 14. doi: 10.1038/ajg. 2015.112
- Rudolph G, Gotthardt D, Kloters-Plachky P, et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. J Hepatol. 2009;51(1):149-55. doi: 10.1148/radiol.10091953
- Chapman M.H, Webster G.J, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: A 25-year single - centre experience. Eur J Gastroenterol Hepatol. 2012;24(9):1051-8. doi: 10.1097/meg.0b013e3283554bbf
- Bjornsson E. Small - duct primary sclerosing cholangitis. Curr Gastroenterol Rep. 2009;11(1):37-41. doi: 10.1007/s11894-009-0006-6
- Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small - duct primary sclerosing cholangitis. Gastroenterology. 2008;134(4):975-80. doi: 10.1053/j.gastro.2008.01.042
- Björnsson E, Boberg K.M, Cullen S, Fleming K, Clausen O.P, Fausa O, Schrumpf E, Chapman R.W. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002;51:731-5. doi: 10.1136/gut.51.5.731
- Khosroshahi A, Wallace Z.S, Crowe J.L, Akamizu T, et al.; Second International Symposium on IgG4-Related Disease. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheum. 2015;67(7):1688-99. doi: 10.1002/art.39132
- Culver E.L, Chapman R.W. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther. 2011;33(12):1273-91. doi: 10.1111/j.1365-2036.2011.04658.x
- Zhou X.P, Liu B, Xu Q, Yang Y, He C.X, Zuo Y.G, Liu Y.H. Serum levels of immunoglobulins G1 and G4 targeting the non - collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis. Dermatology. 2016;43(2):141-8. doi: 10.1111/j.1365-2036.2011.04658.x
- Ryu J.H, Horie R, Sekiguchi H, Peikert T, Yi E.S. Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice. Int J Rheumatol. 2012;2012:232960. doi: 10.1155/2012/232960
- Rossi R.E, Conte D, Massironi S. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. Eur J Gastroenterol Hepatol. 2016;28:123-31. doi: 10.1097/meg.0000000000000532
- Tischendorf J.J, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol. 2007;102:107-14. doi: 10.1097/meg.0000000000000532
- Kashyap R, Safadjou S, Chen R, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases - an analysis of the UNOS database. J Gastrointest Surg. 2010;14:1362-9. doi: 10.1007/s11605-010-1256-1
- Goldberg D, Bittermann T, Makar G. Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant. 2012;12:1603-9. doi: 10.1111/j.1600-6143.2011.03969.x
- De Vries A.B, Janse M, Blokzijl H, Weersma R.K. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21:1956-71. doi: 10.3748/wjg.v21.i6.1956
Supplementary files
